Treatment guidelines: latest news

Treatment guidelines resources

Treatment guidelines features

Treatment guidelines news from aidsmap

More news

Treatment guidelines news selected from other sources

  • Guidelines Advise Against Tenofovir for HIV Patients With Kidney Disease

    HIV-positive patients who have reduced kidney function should take antiretroviral therapy, but should avoid regimens that contain tenofovir (Viread), according to updated treatment guidelines from the HIV Medicine Association (HIVMA).

    22 September 2014 | The Body Pro
  • Malawi First Country to Put HIV Positive Pregnant Women On ARVs

    President Arthur Peter Mutharika says Malawi was the first country to adopt a policy of putting all HIV positive pregnant and breast feeding women on anti-retroviral (ARV) drugs regardless of their CD4 Count.

    02 September 2014 | AllAfrica
  • HIV drugs treatment to start earlier - Motsoaledi

    South Africa will start treating HIV-positive patients at an earlier stage starting next year, Health Minister Aaron Motsoaledi said on Wednesday.

    23 July 2014 | Independent Online
  • Global Policy, Local Disconnects A look into the implementation of the 2013 HIV treatment GuideLines

    The Global Policy, Local Disconnects: A Look Into the Implementation of the 2013 HIV Treatment Guidelines report is a global initiative undertaken by ITPC and the AIDS and Rights Alliance for Southern Africa (ARASA). The research conducted and compiled in this report has been carried out by ITPC’s nine regional networks staff teams, ARASA and our respective country partners.

    20 July 2014 | International Treatment Preparedness Coalition
  • Three Top Researchers Question Efavirenz Status as First-Line Agent

    Looking at recent evidence, three top clinical investigators question whether the nonnucleoside efavirenz should maintain its rank as a preferred first-line antiretroviral.

    14 July 2014 | International AIDS Society
  • Switch from single-tablet regimen to 3 tablets works in Denmark

    Switching from an efavirenz-containing single-tablet regimen (STR) to an efavirenz containing triple-tablet regimen (TTR) to save money maintained viral suppression in Denmark. Antiretroviral-naive people who started the TTR attained the same virologic suppression rate as people who started the STR combination.

    10 July 2014 | International AIDS Society
  • New ARV prescribing guidelines for London (2014)

    The guidelines are the result of a therapeutic tender, which encourages drug manufacturers to offer volume discounts for different stages of the treatment pathway, for example, for preferred use in first-line, second-line and multiple resistant treatment.

    01 July 2014 | HIV i-Base
  • Dolutegravir in HIV-1 infection: Added benefit in adult patients

    The German Institute for Quality and Efficiency in Health Care (IQWiG) has determined that the new integrase inhibitor drug dolutegravir (Tivicay ®) is of considerable added benefit to treatment-naive patients in comparison with current first-line therapies, and some added benefit to patients who already need to take an integrase inhibitor.

    19 June 2014 | Science Daily
  • AAHIVM, AGS, and ACRIA release updated recommendations for older patients with HIV

    The American Academy of HIV Medicine (AAHIVM), ACRIA, and the American Geriatrics Society (AGS) this week announced a major update to its 2011 report, Recommended Treatment Strategies for Clinicians Managing Older Patients with HIV. Revised topics include assessing functional capacity, smoking cessation, and management of diabetes, COPD, osteoporosis, and hypertension.

    06 June 2014 | EATG
  • Divided Opinions on Feasibility of Kenya’s Option B+ Roll Out

    Kenya’s health sector has been facing significant challenges, ranging from a shortage of health care providers to a series of labour strikes. The problems have not only disrupted health services, but have HIV experts divided on whether to roll out Option B+ nationwide or just to pilot it in high volume facilities such as major referral hospitals.

    29 May 2014 | Inter Press Service
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also